Research on biomarkers for cancer treatment response and survival
Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment
This study is trying to find markers in blood samples that can help predict how well cancer patients will respond to treatment and how long they might live.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Antoine Lacassagne Academic / other |
| Locations | 1 site (Nice) |
| Trial ID | NCT06851975 on ClinicalTrials.gov |
What this trial studies
This study investigates biomarkers that may predict how well patients with cancer respond to treatment and their overall survival. It involves collecting blood samples from patients who are undergoing standard care procedures, such as blood tests or venous line insertions. The goal is to analyze these samples to identify potential indicators of treatment efficacy and patient outcomes. Participants must consent to the use of their data for medical research purposes.
Who should consider this trial
Good fit: Ideal candidates are patients scheduled for blood tests or venous line insertions as part of their standard cancer care.
Not a fit: Patients who are already enrolled in the study or considered vulnerable individuals may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized cancer treatments based on individual biomarker profiles.
How similar studies have performed: Other studies have shown promise in using biomarkers to predict cancer treatment outcomes, indicating that this approach has potential.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient having a blood test, venous line insertion or injection on an implantable venous device scheduled as part of their standard care, * Patient who has read the information note and stated that he/she has no objections * Patient who has not objected to the use of this data for medical research purposes * Patient with social security cover. Exclusion Criteria: * Patient already included in the study * Patient considered to be a vulnerable person; vulnerable persons are defined in article L1121-5 to -8
Where this trial is running
Nice
- Centre Antoine Lacassagne — Nice, France (Recruiting)
Study contacts
- Study coordinator: Victoria FERRARI, Dr
- Email: victoria.ferrari@nice.unicancer.fr
- Phone: +33 492031311
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.